Beyond ALK-RET, ROS1 and other oncogene fusions in lung cancer

Fusions of the RET and ROS1 protein tyrosine kinase oncogenes with several partner genes were recently identified as new targetable genetic aberrations in cases of non-small cell lung cancer (NSCLC) lacking activating EGFR, KRAS, ALK, BRAF, or HER2 oncogene aberrations. RET and ROS1 fusion-positive...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Transl Lung Cancer Res
Huvudupphovsmän: Kohno, Takashi, Nakaoku, Takashi, Tsuta, Koji, Tsuchihara, Katsuya, Matsumoto, Shingo, Yoh, Kiyotaka, Goto, Koichi
Materialtyp: Artigo
Språk:Inglês
Publicerad: AME Publishing Company 2015
Ämnen:
Review Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4384213/
https://ncbi.nlm.nih.gov/pubmed/25870798
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2218-6751.2014.11.11
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk